Use of self-expanding vascular endoprostheses in superior vena cava syndrome

Mónaco, R. García; Bertoni, H.; Pallota, G.; Lastiri, R.; Varela, M.; Beveraggi, E.M.; Vassallo, B.C.
August 2003
European Journal of Cardio-Thoracic Surgery;Aug2003, Vol. 24 Issue 2, p208
Academic Journal
Introduction: Superior vena cava syndrome (SVCS) is associated to a malignant tumor in more than 90% of cases; being the lung cancer the most frequent (80%). SVCS has a benign cause in less than 5% of cases. Endovascular stenting has been proposed as the primary treatment of choice. We report our experience in SVC recanalization through the use of self-expanding vascular stents as treatment of life-threatening SVCS of benign and malignant etiology. Materials and methods: Between January 1994 and April 2002 44 patients with critical SVCS, were treated at the Hospital Italiano de Buenos Aires. Forty nine self-expanding endovascular metallic stents were percutaneously placed in the SVC. Thirty-one (70%) patients were male and 13 (30%) were female. The mean age was 55.6 years (range: 21–77). The etiology of SVCS was malignant in 40 cases and benign in 4. The malignant causes included lung cancer: 37 (37/44–92.5%), lymphoma: 1 (2.5%), chondrosarcoma 1 (2.5%), melanoma 1 (2.5%). The benign etiology corresponded to central catheters (n: 2) and post-radiation fibrosis (n: 2). Cavography showed complete occlusion of SVC in 12 cases (27%) and significant partial stenosis in 32 cases (73%). Thrombi associated with tumor stenosis were present in 25 (57%) patients. Results: All procedures were technically successful. No stent migration was observed. Thirty-two patients with malignant tumor ultimately died due to the progression of the disease. Mean survival time was 193 days (range: 25–578). SVCS recurrence was observed on six occasions. In four patients a new stent was placed. Symptomatic improvement was dramatically seen within 24–48 h after stent placement in 40 patients (90.9%) and 83.3% out of the cases (38/44) were symptoms-free during the rest of the disease. Three patients died in the 7 following days. Conclusion: The use of self-expanding vascular endoprostheses in the recanalization treatment of SVC in SVCS due to a malignant or benign etiology offers excellent results with rapid and prolonged remission of symptoms.


Related Articles

  • Cough and neck swelling clinch a diagnosis. Petty, Thomas L. // Cortlandt Forum;09/25/97, Vol. 10 Issue 9, p249 

    Presents a case study of a man diagnosed with lung cancer and superior vena cava syndrome. Symptoms of neck swelling accompanied by a cough; Speculation that patient may have tuberculosis; X-ray examination revealing mass on right chest; Biopsy results showing presence of squamous cell...

  • FOCAL HEPATIC ENHANCEMENT IN SUPERIOR VENA CAVA OBSTRUCTION. Ismail, Siti Suhaila; Mohamed, Siti Jusna; J., Win Mar@Salmah; Kareem, Abdul // Malaysian Journal of Medical Sciences;Jan2006 Supplement, Vol. 13, p147 

    Introduction: Compression to the superior vena cava (SVC) as a complication of malignant or benign disease that compressed, invade or occlude the SVC causing development of collateral routes to the liver is uncommom. A case of patient diagnosed of having small cell bronchogenic carcinoma...

  • A rare cause of superior vena cava obstruction. Harrison, TW // BMJ: British Medical Journal (International Edition);11/23/96, Vol. 313 Issue 7068, p1324 

    Discusses the case of a 64 year old man with the classic superior vena cava syndrome. Various causes of the syndrome; Case history; Comments concerning the case; Primary cardiac lymphoma as a rare condition; Linkage between the recurrent attacks of pleuritic-type chest pain and the final...

  • Atherectomy for a blocked SVC? H.D.B. // Cortlandt Forum;05/25/97, Vol. 10 Issue 5, p112 

    Responds to a question related to the treatment of a complete obstruction of the superior vena cava (SVC). Possible use of atherectomy or cardiac laser technology in reopening the blocked SVC.

  • Superior vena cava syndrome: a rare clinical manifestation of Behçet’s disease. Hanta, Ismail; Ucar, Gamze; Kuleci, Sedat; Ozbek, Süleyman; Kocabas, Ali // Clinical Rheumatology;Jun2005, Vol. 24 Issue 3, p314 

    Presents a letter to the editor concerning the article, "Superior vena cava syndrome: a rare clinical manifestation of Behcet's disease,"published in the September 2004 issue of thejournal, "Clinical Rheumatology."

  • Treatment of superior vena caval syndrome. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;03/25/98, Vol. 11 Issue 3, p24 

    Discusses the pathophysiology and treatment of superior vena caval (SVC) syndrome. Signs and symptoms of the disease; SVC as an oncologic emergency that requires an immediate mediastinal irradiation; Importance of irradiation.

  • Being there. Felder, Michael // Cortlandt Forum;03/25/98, Vol. 11 Issue 3, p61 

    Recounts the author's decision to administer a euthanasia to his female patient who was diagnosed with superior vena cava (SVC) syndrome. Signs and symptoms of the disease; Request for the withdrawal of the endotracheal tube; Administration of gradual increasing doses of morphine and sedative.

  • Cardiac Herniation and Torsion. Buniva, Paolo; Aluffi, Alessandro; Rescigno, Giuseppe; Rademacher, Johannes; Nazari, Stefano // Texas Heart Institute Journal;2001, Vol. 28 Issue 1, p73 

    Presents a case study of a patient undergoing a right pneumonectomy for bronchogenic cancer who underwent tangential resection of the superior vena cava, infiltrated by the tumor. Details on the surgical procedure conducted; Information on cardiac herniation after partial pericardiectomy during...

  • Relief of sleep apnea after intravascular stenting for superior vena cava syndrome. Fernandez Jr, B.; Smolley, L.A.; Kaye, M.D.; Swirsky, S.M. // Vascular Medicine;1999, Vol. 4 Issue 1, p33 

    A rarely reported association of sleep apnea and superior vena cava stenosis from mediastinal fibrosis is described. A case is presented where substantial improvement in the sleep parameters and the symptoms of sleep apnea occurred subsequent to superior vena cava thrombolysis and stent angioplasty.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics